tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Positive Outlook on Ventyx Biosciences Due to Promising Developments in Neuro-Inflammatory Treatments
PremiumRatingsPositive Outlook on Ventyx Biosciences Due to Promising Developments in Neuro-Inflammatory Treatments
3M ago
Positive Buy Rating for Ventyx Biosciences Driven by Promising Phase 2a Trial Results and Strong Financial Position
Premium
Ratings
Positive Buy Rating for Ventyx Biosciences Driven by Promising Phase 2a Trial Results and Strong Financial Position
3M ago
Ventyx Biosciences Announces Positive Phase 2a Trial Results
Premium
Company Announcements
Ventyx Biosciences Announces Positive Phase 2a Trial Results
4M ago
Ventyx Biosciences: Strategic Investment by Sanofi Highlights Promising Prospects and Innovative Approach
PremiumRatingsVentyx Biosciences: Strategic Investment by Sanofi Highlights Promising Prospects and Innovative Approach
4M ago
Buy Rating for Ventyx Biosciences: Promising Clinical Trials and Strong Financial Position
Premium
Ratings
Buy Rating for Ventyx Biosciences: Promising Clinical Trials and Strong Financial Position
5M ago
Ventyx Biosciences: Promising Pipeline and Upcoming Data Readouts Justify Buy Rating
Premium
Ratings
Ventyx Biosciences: Promising Pipeline and Upcoming Data Readouts Justify Buy Rating
5M ago
Ventyx Biosciences Faces Supply Chain Risks Amidst U.S.-China Tensions and Regulatory Challenges
PremiumCompany AnnouncementsVentyx Biosciences Faces Supply Chain Risks Amidst U.S.-China Tensions and Regulatory Challenges
7M ago
Ventyx Biosciences reports Q4 EPS (41c), consensus (55c)
Premium
The Fly
Ventyx Biosciences reports Q4 EPS (41c), consensus (55c)
7M ago
Ventyx Biosciences’ VTX958 shows efficacy in Crohn’s Disease
Premium
The Fly
Ventyx Biosciences’ VTX958 shows efficacy in Crohn’s Disease
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100